• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺肉瘤的流行病学和淋巴结清扫术在子宫腺肉瘤中的逆概率治疗加权(IPTW)调整生存分析。

Epidemiology of adenosarcoma and the inverse probability of treatment weighting (IPTW) adjusted survival analysis of lymph node dissection in uterine adenosarcoma.

机构信息

Key Laboratory of Gene Editing Screening and R&D of Digestive System Tumor Drugs, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Medicine (Baltimore). 2022 Sep 23;101(38):e30607. doi: 10.1097/MD.0000000000030607.

DOI:10.1097/MD.0000000000030607
PMID:36197202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9509147/
Abstract

The objective for the study was to analysis the epidemiology of adenosarcoma, and independent prognostic factors and impact of lymph node dissection (LND) of uterine adenosarcoma. Cases of patients with primary adenosarcoma were obtained from the Surveillance, Epidemiology, and End Results (SEER) database from 2000 to 2016. Overall survival was analyzed by the Kaplan-Meier method and log-rank test. The differences in baseline covariates between the 2 groups were adjusted by inverse probability of treatment weighting method. The prognostic factors were identified by univariate and multivariate Cox regression analysis and hazard ratio and 95% confidence interval (CI) of covariates were also estimated. 1129 patients with pathological primary adenosarcoma between 2000 and 2016 were identified from the surveillance, epidemiology, and end results database. The only 4 patients were male. 1027 patients with primary uterine adenosarcoma, and 53.1% underwent LND and only 3.5% patients were with positive lymph node. Age, marital status, largest tumor size, tumor grade, T stage and chemotherapy were significantly correlated with survival. Race, tumor number, LND, and radiotherapy did not affect overall survival in patients. Inverse probability of treatment weighting-adjusted K-M curve showed that LND did not improve survival and lymph node metastasis (LNM) did not affect survival. The majority of primary adenosarcoma patients are female with high incidence of uterus and rare incidence of distant metastasis. Age, marital status, tumor size, T stage, grade, and chemotherapy are independent prognostic factors of uterine adenosarcoma. LNM was not a significant prognostic risk factor, and LND did not benefit survival.

摘要

本研究旨在分析子宫腺肉瘤的流行病学特征,以及独立的预后因素和淋巴结清扫(LND)对子宫腺肉瘤的影响。从 2000 年至 2016 年,从监测、流行病学和最终结果(SEER)数据库中获取了原发性腺肉瘤患者的病例。采用 Kaplan-Meier 方法和对数秩检验分析总生存率。通过逆概率处理权重法调整两组间基线协变量的差异。通过单因素和多因素 Cox 回归分析确定预后因素,并估计协变量的风险比和 95%置信区间(CI)。从监测、流行病学和最终结果数据库中确定了 2000 年至 2016 年间 1129 例病理原发性腺肉瘤患者。仅 4 例为男性。1027 例原发性子宫腺肉瘤患者中,53.1%行 LND,仅 3.5%患者淋巴结阳性。年龄、婚姻状况、最大肿瘤大小、肿瘤分级、T 分期和化疗与生存显著相关。种族、肿瘤数量、LND 和放疗对患者的总生存率没有影响。经过处理权重校正的 K-M 曲线表明,LND 并不能提高生存率,且淋巴结转移(LNM)并不影响生存。大多数原发性腺肉瘤患者为女性,子宫发病率高,远处转移率低。年龄、婚姻状况、肿瘤大小、T 分期、分级和化疗是子宫腺肉瘤的独立预后因素。LNM 不是显著的预后危险因素,LND 不能提高生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e860/9509147/89548d1aa73b/medi-101-e30607-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e860/9509147/367d152e8c58/medi-101-e30607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e860/9509147/6418a0e441e4/medi-101-e30607-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e860/9509147/89548d1aa73b/medi-101-e30607-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e860/9509147/367d152e8c58/medi-101-e30607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e860/9509147/6418a0e441e4/medi-101-e30607-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e860/9509147/89548d1aa73b/medi-101-e30607-g003.jpg

相似文献

1
Epidemiology of adenosarcoma and the inverse probability of treatment weighting (IPTW) adjusted survival analysis of lymph node dissection in uterine adenosarcoma.腺肉瘤的流行病学和淋巴结清扫术在子宫腺肉瘤中的逆概率治疗加权(IPTW)调整生存分析。
Medicine (Baltimore). 2022 Sep 23;101(38):e30607. doi: 10.1097/MD.0000000000030607.
2
Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.肝内胆管癌准确的淋巴结分期需要充分的淋巴结清扫: 一项基于人群的研究。
Cancer Med. 2023 Apr;12(7):8184-8198. doi: 10.1002/cam4.5620. Epub 2023 Jan 16.
3
The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.根治性前列腺切除术治疗转移性前列腺癌患者淋巴结清扫的影响:生存和术后早期结局的当代分析。
Eur Urol Oncol. 2019 Sep;2(5):541-548. doi: 10.1016/j.euo.2018.10.010. Epub 2018 Nov 22.
4
Significance of lymph node metastasis on survival of women with uterine adenosarcoma.淋巴结转移对子宫腺肉瘤女性患者生存的意义。
Gynecol Oncol. 2017 Mar;144(3):524-530. doi: 10.1016/j.ygyno.2017.01.012. Epub 2017 Jan 18.
5
Prognostic value of lymph node density on cancer staging system for gastric cancer without distal metastasis: a population-based analysis of SEER database.无远处转移胃癌淋巴结密度在癌症分期系统中的预后价值:基于 SEER 数据库的人群分析。
World J Surg Oncol. 2022 Sep 29;20(1):325. doi: 10.1186/s12957-022-02795-9.
6
Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study.苗勒管腺肉瘤女性患者的生存情况:一项国家癌症数据库研究。
Gynecol Oncol. 2016 Dec;143(3):636-641. doi: 10.1016/j.ygyno.2016.10.013. Epub 2016 Oct 20.
7
Lymph Nodes Dissection in Elderly Patients with T3-T4 Laryngeal Cancer.老年 T3-T4 声门型喉癌患者行淋巴结清扫术。
Clin Interv Aging. 2020 Dec 8;15:2321-2330. doi: 10.2147/CIA.S283600. eCollection 2020.
8
The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT non-metastatic renal cell carcinoma treated with radical nephrectomy.淋巴结清扫和阳性淋巴结对接受根治性肾切除术治疗的当代pT期非转移性肾细胞癌患者癌症特异性死亡率的影响。
BJU Int. 2018 Mar;121(3):383-392. doi: 10.1111/bju.14024. Epub 2017 Oct 12.
9
Primary tumor resection and lymph node dissection improve survival in metastatic pancreatic ductal adenocarcinoma: an inverse probability of treatment weighting analysis.原发性肿瘤切除和淋巴结清扫可提高转移性胰腺导管腺癌的生存率:一项治疗权重逆概率分析。
Transl Cancer Res. 2020 May;9(5):3312-3323. doi: 10.21037/tcr.2020.04.02.
10
Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.评估淋巴结清扫术和放射治疗对子宫癌肉瘤患者的影响:一项监测、流行病学和最终结果(SEER)分析
Gynecol Oncol. 2008 Oct;111(1):82-8. doi: 10.1016/j.ygyno.2008.05.016.

引用本文的文献

1
A Rare Case of Endometrial Adenosarcoma and Its Management: A Case Report and Literature Review.子宫内膜腺肉瘤罕见病例及其处理:一例报告并文献复习
Cureus. 2025 Mar 3;17(3):e79970. doi: 10.7759/cureus.79970. eCollection 2025 Mar.
2
Next-Generation Sequencing Analysis of 3 Uterine Adenosarcomas with Heterogeneously Differentiated Genomic Mutations.3例具有异质性分化基因组突变的子宫腺肉瘤的下一代测序分析
Int J Anal Chem. 2023 Sep 28;2023:7436368. doi: 10.1155/2023/7436368. eCollection 2023.
3
Uterine adenosarcoma: a case report and review of the literature.

本文引用的文献

1
Uterine Preservation Treatments in Sarcomas: Oncological Problems and Reproductive Results: A Systematic Review.子宫肉瘤的保留子宫治疗:肿瘤学问题与生殖结局:一项系统综述
Cancers (Basel). 2021 Nov 19;13(22):5808. doi: 10.3390/cancers13225808.
2
Primary biliary adenosarcoma of the liver-a special and new entity.原发性肝腺样血管肉瘤——一种特殊而新颖的实体瘤。
Virchows Arch. 2020 Sep;477(3):461-466. doi: 10.1007/s00428-020-02783-y. Epub 2020 Mar 26.
3
A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China.
子宫腺肉瘤:一例病例报告及文献综述
Am J Nucl Med Mol Imaging. 2023 Apr 25;13(2):70-76. eCollection 2023.
中国西部真实世界的子宫肉瘤诊治研究。
Int J Biol Sci. 2020 Jan 1;16(3):388-395. doi: 10.7150/ijbs.39773. eCollection 2020.
4
Uterine Adenosarcoma.子宫腺肉瘤。
Oncol Res Treat. 2018;41(11):693-696. doi: 10.1159/000494067. Epub 2018 Oct 17.
5
Prognostic factors for uterine adenosarcoma: a review.子宫腺肉瘤的预后因素:综述。
Expert Rev Anticancer Ther. 2018 Nov;18(11):1093-1100. doi: 10.1080/14737140.2018.1518136. Epub 2018 Sep 11.
6
The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes.淋巴血管浸润在子宫腺肉瘤中的重要性:临床、预后和治疗结果分析。
Int J Gynecol Cancer. 2018 Sep;28(7):1297-1310. doi: 10.1097/IGC.0000000000001306.
7
Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review.原发性子宫外和卵巢外苗勒管腺肉瘤:病例报告及文献复习。
BMC Cancer. 2018 Feb 5;18(1):134. doi: 10.1186/s12885-018-4037-y.
8
A case of a primary hepatic so-called adenosarcoma with heterotopic ossification: possibly of biliary adenofibroma origin.原发性肝脏所谓的腺肉瘤伴骨化病例:可能来源于胆管腺瘤样纤维瘤。
Hum Pathol. 2018 Mar;73:108-113. doi: 10.1016/j.humpath.2017.10.009. Epub 2017 Oct 24.
9
Significance of lymph node metastasis on survival of women with uterine adenosarcoma.淋巴结转移对子宫腺肉瘤女性患者生存的意义。
Gynecol Oncol. 2017 Mar;144(3):524-530. doi: 10.1016/j.ygyno.2017.01.012. Epub 2017 Jan 18.
10
Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study.苗勒管腺肉瘤女性患者的生存情况:一项国家癌症数据库研究。
Gynecol Oncol. 2016 Dec;143(3):636-641. doi: 10.1016/j.ygyno.2016.10.013. Epub 2016 Oct 20.